JP Morgan Maintains Neutral on Amrize, Lowers Price Target to $48
JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Neutral and lowers the price target from $52 to $48.
Stocks · News reference
RBC Capital Maintains Underperform on Amrize, Lowers Price Target to $32
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading